LNA Santé Past Earnings Performance

Past criteria checks 2/6

LNA Santé has been growing earnings at an average annual rate of 10.1%, while the Healthcare industry saw earnings growing at 10.6% annually. Revenues have been growing at an average rate of 8.2% per year. LNA Santé's return on equity is 7.9%, and it has net margins of 3.1%.

Key information

10.1%

Earnings growth rate

8.3%

EPS growth rate

Healthcare Industry Growth15.7%
Revenue growth rate8.2%
Return on equity7.9%
Net Margin3.1%
Last Earnings Update30 Jun 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How LNA Santé makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:2N3 Revenue, expenses and earnings (EUR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 2476224800
31 Mar 2474924780
31 Dec 2373623760
30 Sep 2373424750
30 Jun 2373224740
31 Mar 2373025740
31 Dec 2272826740
30 Sep 2272026780
30 Jun 2271126830
31 Mar 2270025820
31 Dec 2168924820
30 Sep 2166220780
30 Jun 2163416740
31 Mar 2160412700
31 Dec 205748670
30 Sep 2056210650
30 Jun 2055113640
31 Mar 2053917610
31 Dec 1952821590
30 Sep 1953121710
30 Jun 1953422830
31 Mar 1953622950
31 Dec 18539221070
30 Sep 18522231020
30 Jun 1850525960
31 Mar 1849625940
31 Dec 1748724930
30 Sep 1749224950
30 Jun 1749724980
31 Mar 1748623960
31 Dec 1647522940
30 Sep 1644917920
30 Jun 1642313910
31 Mar 1642412900
31 Dec 1542511890
30 Sep 1541110860
30 Jun 153989830
31 Mar 153778800
31 Dec 143567770
30 Sep 143488750
30 Jun 143408720
31 Mar 143328690
31 Dec 133248650

Quality Earnings: 2N3 has high quality earnings.

Growing Profit Margin: 2N3's current net profit margins (3.1%) are lower than last year (3.3%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 2N3's earnings have grown by 10.1% per year over the past 5 years.

Accelerating Growth: 2N3's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 2N3 had negative earnings growth (-1.5%) over the past year, making it difficult to compare to the Healthcare industry average (40.5%).


Return on Equity

High ROE: 2N3's Return on Equity (7.9%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies